Neogen Chemicals Ltd. (NEOGEN) AI Stock Analysis

• Market Cap: ₹38.85B
• Dividend Yield: 0.09%
• Average Volume (3M): 9.36K
• Price to Earnings (P/E): 115.5
• Beta (1Y): 1.36
• Revenue Growth: 8.44%
• EPS Growth: -35.59%
• Country: IN
• Employees: 588
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 1.30
• Shares Outstanding: 26,381,674
• 10 Day Avg. Volume: 1,157
• 30 Day Avg. Volume: 9,357
• PEG Ratio: -22.51
• Price to Book (P/B): 5.41
• Price to Sales (P/S): 5.49
• P/FCF Ratio: -35.07
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 51 Neutral
• Price Target: ₹1,317.00 ▲(17.06% Upside)

Neogen Chemicals Ltd. faces significant challenges with its high valuation and bearish technical indicators. While financial performance shows growth potential, the company's profitability and cash flow issues, combined with high leverage, are concerning. The lack of positive earnings call insights further limits the stock's appeal.

Positive Factors

Revenue Growth

Neogen Chemicals' strong revenue growth indicates robust demand for its specialty chemicals and effective market penetration, supporting long-term business expansion.

Operational Efficiency

Efficient cost management reflected in a healthy gross profit margin suggests Neogen Chemicals can maintain competitive pricing and profitability over time.

Product Innovation

Neogen Chemicals' commitment to R&D and product innovation allows it to adapt to market needs, ensuring long-term relevance and competitive advantage.

Negative Factors

Profitability Challenges

Low net profit margins indicate that despite revenue growth, high operational costs are impacting Neogen Chemicals' ability to convert sales into profits, which could hinder long-term financial health.

Cash Flow Volatility

Volatile cash flows and negative free cash flows suggest potential cash management issues, impacting Neogen Chemicals' ability to invest in growth and meet financial obligations.

High Leverage

High leverage poses risks to Neogen Chemicals' financial stability, as it may limit flexibility and increase vulnerability to economic downturns, affecting long-term sustainability.

Neogen Chemicals Ltd. Business Overview & Revenue Model

Company Description

Neogen Chemicals Ltd. (NEOGEN) is a leading manufacturer and supplier of specialty chemicals in India, primarily focused on the production of bromine-based compounds, custom synthesis, and other specialty chemicals. The company serves various sectors including pharmaceutical, agrochemical, and specialty chemical industries, providing high-quality products that cater to specific customer needs. NEOGEN is known for its commitment to innovation and sustainability, aligning its operations with environmental standards and practices.

How the Company Makes Money

Neogen Chemicals generates revenue through multiple streams including the sale of specialty chemicals, custom synthesis services, and the manufacturing of bromine-based compounds. The company's revenue model is primarily based on direct sales to clients in various sectors such as pharmaceuticals and agrochemicals, where it provides tailored chemical solutions. Additionally, NEOGEN benefits from long-term partnerships with key players in these industries, which contribute to stable revenue. The company's focus on research and development also enables it to introduce new products, thereby expanding its market reach and enhancing earnings potential.

Neogen Chemicals Ltd. Financial Statement Overview

Summary

Neogen Chemicals Ltd. shows promising growth in revenue and operational efficiencies. However, challenges with profitability and cash flow management, along with increasing leverage, could pose risks if not managed prudently.

Income Statement

The company has demonstrated strong revenue growth with a significant increase from 2024 to 2025. The gross profit margin is healthy, indicating efficient cost management. However, net profit margins are relatively low, suggesting that operational costs and other expenses are eroding profitability. The EBIT and EBITDA margins are improving, showing positive operational efficiency.

Balance Sheet

The balance sheet reflects a robust equity position with a steady increase in stockholders' equity over the years. However, the debt-to-equity ratio is relatively high, indicating significant leverage which could pose risks in terms of financial stability. The equity ratio suggests a balanced approach to asset financing.

Cash Flow

The company's cash flow statements indicate volatility, with negative free cash flows in recent years despite improved operating cash flows. This suggests potential cash management challenges. The operating cash flow to net income ratio indicates that cash generation from operations is not consistently translating into profitability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.84B	7.78B	6.91B	6.86B	4.87B	3.36B
Gross Profit	3.56B	3.54B	1.42B	2.98B	1.40B	969.86M
EBITDA	1.40B	1.36B	1.13B	1.16B	865.60M	644.96M
Net Income	336.40M	348.30M	356.50M	499.70M	446.30M	313.30M
Balance Sheet
Total Assets	0.00	17.47B	14.61B	10.54B	7.99B	4.92B
Cash, Cash Equivalents and Short-Term Investments	49.60M	49.60M	124.90M	967.60M	1.14B	5.10M
Total Debt	0.00	5.97B	4.09B	3.70B	2.29B	2.22B
Total Liabilities	-7.89B	9.58B	7.01B	5.71B	3.60B	3.09B
Stockholders Equity	7.89B	7.89B	7.60B	4.83B	4.39B	1.83B
Cash Flow
Free Cash Flow	0.00	-1.22B	-3.32B	-1.34B	-1.69B	-514.61M
Operating Cash Flow	0.00	1.96B	-291.50M	-303.50M	14.10M	835.70M
Investing Cash Flow	0.00	-3.17B	-2.16B	-944.60M	-1.46B	-1.35B
Financing Cash Flow	0.00	1.13B	2.37B	1.00B	1.88B	507.27M

Neogen Chemicals Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1125.05
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NEOGEN, the sentiment is Negative. The current price of 1125.05 is below the 20-day moving average (MA) of 1304.71, below the 50-day MA of 1425.34, and below the 200-day MA of 1563.95, indicating a bearish trend. The MACD of -72.87 indicates Positive momentum. The RSI at 31.77 is Neutral, neither overbought nor oversold. The STOCH value of 27.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NEOGEN.

Neogen Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ROSSARI	70 Outperform	₹32.92B	24.08	―	0.08%	15.47%	-1.72%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
BALAMINES	61 Neutral	₹45.54B	29.91	―	0.95%	-10.76%	-27.70%
UFLEX	61 Neutral	₹36.02B	9.23	―	0.60%	7.44%	―
HIKAL	52 Neutral	₹29.64B	46.83	―	0.63%	-6.72%	-86.26%
NEOGEN	51 Neutral	₹38.85B	115.48	―	0.09%	8.44%	-35.59%
TIRUMALCHM	41 Neutral	₹28.81B	―	―	0.42%	-11.11%	-340.74%

Neogen Chemicals Ltd. Corporate Events

Neogen Chemicals Ltd. Reports Successful AGM with All Resolutions Approved

Neogen Chemicals Ltd. announced the successful conclusion of its 36th Annual General Meeting held on September 26, 2025, where all resolutions were approved by the shareholders with the requisite majority. The company submitted the scrutinizer’s report and voting results, which are available on its website, reflecting compliance with SEBI regulations and demonstrating strong shareholder support.

Neogen Chemicals Ltd. Successfully Concludes 36th AGM with Shareholder Approval

Neogen Chemicals Ltd. announced the successful conclusion of its 36th Annual General Meeting, where all resolutions proposed were approved by the shareholders with the required majority. The meeting was conducted through video conferencing, and the scrutinizer’s report, detailing the voting results, has been made available on the company’s website. This development signifies strong shareholder support and compliance with regulatory requirements, potentially enhancing the company’s governance and stakeholder confidence.

Neogen Chemicals Conducts 36th AGM via Video Conferencing

Neogen Chemicals Ltd. held its 36th Annual General Meeting (AGM) on September 26, 2025, via video conferencing, adhering to regulatory guidelines. The meeting, chaired by Mr. Haridas Kanani, included discussions on e-voting procedures and the introduction of board members and auditors. The AGM was attended by the requisite number of members, ensuring a quorum, and voting results will be shared shortly.

Neogen Chemicals Ltd. Holds 36th AGM Virtually, Ensures Shareholder Engagement

Neogen Chemicals Ltd. conducted its 36th Annual General Meeting (AGM) on September 26, 2025, through video conferencing, adhering to regulatory guidelines. The meeting, chaired by Haridas Kanani, covered essential proceedings and voting processes, ensuring shareholder participation through electronic means. The AGM confirmed the presence of a quorum and facilitated discussions on company matters, reflecting Neogen’s commitment to transparency and compliance.